3 ms·
Not against researching other candidates as well. But mRNA has a proven track record and extending it to other diseases is a promising track. You can fund rese
by insane_dreamer 1y ago
Not against researching other candidates as well. But mRNA has a proven track record and extending it to other diseases is a promising track.
You can fund research in those other areas without cutting mRNA. Sure it'll cost more $ but there's plenty of that - ffs we're spending $150 billion _more_ on "border security".
- thenerdhead 1y agoYes and those are being funded well. Look at HIV and cancer mRNA breakthroughs. Those aren’t being cut. This is specifically about COVID-19 and flu. Which after 5 years we have better science supporting how to combat them long term. I think a lot of people miss that nuance because of who the message is coming from.
- insane_dreamer 1y ago> Which after 5 years we have better science supporting how to combat them long term. bird flu, not sure; but as for covid no other method has anywhere near the large scale data supporting it since mRNA was the only one deployed to millions. Do I don't really agree that we have "better science" that shows other methods are more effective.
- thenerdhead 1y agoHave you heard of Novavax or any of the intranasal vaccines in late trials?
- insane_dreamer 1y agoYes, but 1) phase3 trials are still underway, and 2) it's good to have alternatives but it doesn't mean their approach is better than mRNA